LSV Asset Management reduced its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 0.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 865,453 shares of the company's stock after selling 1,344 shares during the quarter. LSV Asset Management owned approximately 0.36% of HCA Healthcare worth $299,057,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also recently added to or reduced their stakes in the company. Avantax Advisory Services Inc. boosted its position in shares of HCA Healthcare by 0.4% in the first quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company's stock worth $2,791,000 after buying an additional 32 shares during the period. Catalyst Financial Partners LLC boosted its position in shares of HCA Healthcare by 4.3% in the first quarter. Catalyst Financial Partners LLC now owns 872 shares of the company's stock worth $301,000 after buying an additional 36 shares during the period. Moors & Cabot Inc. boosted its position in shares of HCA Healthcare by 4.8% in the first quarter. Moors & Cabot Inc. now owns 858 shares of the company's stock worth $297,000 after buying an additional 39 shares during the period. Perigon Wealth Management LLC boosted its position in shares of HCA Healthcare by 2.3% in the first quarter. Perigon Wealth Management LLC now owns 1,797 shares of the company's stock worth $621,000 after buying an additional 40 shares during the period. Finally, Barden Capital Management Inc. raised its holdings in shares of HCA Healthcare by 1.4% during the first quarter. Barden Capital Management Inc. now owns 2,921 shares of the company's stock worth $1,009,000 after acquiring an additional 41 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several analysts recently issued reports on the company. Truist Financial increased their price objective on HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a report on Wednesday, July 16th. Baird R W lowered HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Wolfe Research lowered HCA Healthcare from an "outperform" rating to a "peer perform" rating in a report on Monday, July 28th. Bank of America lowered HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 target price on the stock. in a report on Wednesday, July 16th. Finally, Wall Street Zen upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Nine investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $396.46.
View Our Latest Stock Report on HCA Healthcare
Insiders Place Their Bets
In related news, COO Jon M. Foster sold 15,698 shares of the business's stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the transaction, the chief operating officer owned 12,646 shares in the company, valued at $4,670,420.72. The trade was a 55.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 1.30% of the stock is owned by company insiders.
HCA Healthcare Stock Performance
HCA stock traded up $2.85 during trading on Friday, reaching $356.84. 1,369,756 shares of the stock were exchanged, compared to its average volume of 1,628,465. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. The stock has a 50 day simple moving average of $370.66 and a 200-day simple moving average of $347.68. The company has a market capitalization of $85.84 billion, a P/E ratio of 15.00, a price-to-earnings-growth ratio of 1.12 and a beta of 1.39. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14.
HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%. The company had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. During the same period in the previous year, the business earned $5.50 earnings per share. The company's quarterly revenue was up 6.4% on a year-over-year basis. As a group, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.
HCA Healthcare Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.8%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's payout ratio is 12.11%.
HCA Healthcare Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Recommended Stories

Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.